135
Views
25
CrossRef citations to date
0
Altmetric
Original

CENTRAL EFFECT OF BOTULINUM TOXIN TYPE A IN HUMANS

, &
Pages 667-680 | Received 20 Mar 2005, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Raymond L. Rosales, Arlene R. Ng, Mary Mildred Delgado-Delos Santos & Hubert H. Fernandez. (2011) The Broadening Application of Chemodenervation in X-Linked Dystonia-Parkinsonism (Part II): An Open-Label Experience With Botulinum Toxin-A (Dysport®) Injections for Oromandibular, Lingual, and Truncal-Axial Dystonias. International Journal of Neuroscience 121:sup1, pages 44-56.
Read now
Raymond L. Rosales, Mary Mildred Delgado-Delos Santos, Arlene R. Ng, Rosalia Teleg, Marita Dantes, Lillian V. Lee & Hubert H. Fernandez. (2011) The Broadening Application of Chemodenervation in X-Linked Dystonia-Parkinsonism (Part I): Muscle Afferent Block Versus Botulinum Toxin-A in Cervical and Limb Dystonias. International Journal of Neuroscience 121:sup1, pages 35-43.
Read now
Andy Pickett & Raymond L. Rosales. (2011) New Trends in the Science of Botulinum Toxin-A as Applied in Dystonia. International Journal of Neuroscience 121:sup1, pages 22-34.
Read now
Frederick G Freitag. (2007) Botulinum toxin type A in chronic migraine. Expert Review of Neurotherapeutics 7:5, pages 463-470.
Read now

Articles from other publishers (21)

Ella Ryan & Jayashri Kulkarni. (2023) A potential role for onabotulinumtoxinA in the management of Hallucinogen persisting perception disorder. Australasian Psychiatry 31:2, pages 230-231.
Crossref
Eqram Rahman, Hitmi Khalifa Alhitmi & Afshin Mosahebi. (2022) Immunogenicity to Botulinum Toxin Type A: A Systematic Review With Meta-Analysis Across Therapeutic Indications. Aesthetic Surgery Journal 42:1, pages 106-120.
Crossref
Pavel Hok, Tomáš Veverka, Petr Hluštík, Martin Nevrlý & Petr Kaňovský. (2021) The Central Effects of Botulinum Toxin in Dystonia and Spasticity. Toxins 13:2, pages 155.
Crossref
Wei-I Lee, Patrick W. Carney, Andrew J. Hughes & John S. Archer. (2017) Refractory focal motor seizures controlled with intramuscular botulinum toxin. Epilepsy Research 133, pages 93-97.
Crossref
Brian B. Cai, Joseph Francis, Mitchell F. Brin & Ron S. Broide. (2017) Botulinum neurotoxin type A-cleaved SNAP25 is confined to primary motor neurons and localized on the plasma membrane following intramuscular toxin injection. Neuroscience 352, pages 155-169.
Crossref
Aasef G. Shaikh, David S. Zee, J. Douglas Crawford & Hyder A. Jinnah. (2016) Cervical dystonia: a neural integrator disorder. Brain 139:10, pages 2590-2599.
Crossref
Guillaume Caron, Tanguy Marqueste & Patrick Decherchi. (2015) Long-Term Effects of Botulinum Toxin Complex Type A Injection on Mechano- and Metabo-Sensitive Afferent Fibers Originating from Gastrocnemius Muscle. PLOS ONE 10:10, pages e0140439.
Crossref
Michel R. Popoff & Chloé Connan. 2014. Molecular Aspects of Botulinum Neurotoxin. Molecular Aspects of Botulinum Neurotoxin 35 68 .
William Huynh, Arun V. Krishnan, Cindy S.-Y. Lin, Steve Vucic, Pesi Katrak, Michael Hornberger & Matthew C. Kiernan. (2013) Botulinum toxin modulates cortical maladaptation in post-stroke spasticity. Muscle & Nerve 48:1, pages 93-99.
Crossref
Véronique Marchand‐Pauvert, Claire Aymard, Louis‐Solal Giboin, Federica Dominici, Alessandro Rossi & Riccardo Mazzocchio. (2012) Beyond muscular effects: depression of spinal recurrent inhibition after botulinum neurotoxin A. The Journal of Physiology 591:4, pages 1017-1029.
Crossref
Raymond L. Rosales, Keng He Kong, Khean Jin Goh, Witsanu Kumthornthip, Vincent Chung Tong Mok, Mary Mildred Delgado-De Los Santos, Karen Sui Geok Chua, Saini Jeffery bin Freddy Abdullah, Benjamin Zakine, Pascal Maisonobe, Axel Magis & K. S. Lawrence Wong. (2012) Botulinum Toxin Injection for Hypertonicity of the Upper Extremity Within 12 Weeks After Stroke. Neurorehabilitation and Neural Repair 26:7, pages 812-821.
Crossref
Gary W. Lawrence, Saak V. Ovsepian, Jiafu Wang, K. Roger AokiJ. Oliver Dolly. (2011) Extravesicular intraneuronal migration of internalized botulinum neurotoxins without detectable inhibition of distal neurotransmission. Biochemical Journal 441:1, pages 443-452.
Crossref
Francisco J. Palomar & Pablo Mir. (2012) Neurophysiological changes after intramuscular injection of botulinum toxin. Clinical Neurophysiology 123:1, pages 54-60.
Crossref
Raymond L. Rosales, Petr Kanovsky & Hubert H. Fernandez. (2011) What’s the “catch” in upper-limb post-stroke spasticity: Expanding the role of botulinum toxin applications. Parkinsonism & Related Disorders 17, pages S3-S10.
Crossref
Miguel E. Habeych, Aalap C. Shah, Tara N. Nikonow, Jeffrey R. Balzer, Donald J. Crammond, Parthasarathy D. Thirumala, Amin Kassam & Michael Horowitz. (2011) Effect of botulinum neurotoxin treatment in the lateral spread monitoring of microvascular decompression for hemifacial spasm. Muscle & Nerve 44:4, pages 518-524.
Crossref
Chen-Liang Chou, Si-Huei Lee, Shin-Yo Lu, Ko-Lun Tsai, Chung-Yu Ho & Hsuan-Chu Lai. (2010) Therapeutic Effects of Intra-articular Botulinum Neurotoxin in Advanced Knee Osteoarthritis. Journal of the Chinese Medical Association 73:11, pages 573-580.
Crossref
R. L. Rosales & D. Dressler. (2010) On muscle spindles, dystonia and botulinum toxin. European Journal of Neurology 17, pages 71-80.
Crossref
Mark J. Stillman, Robert G. Kaniecki & Frederick R. Taylor. (2009) Abstracts and Citations. Headache: The Journal of Head and Face Pain 49:3, pages 484-494.
Crossref
N. Lapitskaya, O. Gosseries, V. Delvaux, M. Overgaard, F. Nielsen, A. Maertens de Noordhout, G. Moonen & S. Laureys. (2009) Transcranial Magnetic Stimulation in Disorders of Consciousness. Reviews in the Neurosciences 20:3-4.
Crossref
Flavia Antonucci, Chiara Rossi, Laura Gianfranceschi, Ornella Rossetto & Matteo Caleo. (2008) Long-Distance Retrograde Effects of Botulinum Neurotoxin A. The Journal of Neuroscience 28:14, pages 3689-3696.
Crossref
Jae-Young LimJae-Hyeon KohNam-Jong Paik. (2008) Intramuscular Botulinum Toxin-A Reduces Hemiplegic Shoulder Pain. Stroke 39:1, pages 126-131.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.